NeXtGen Biologics, INC

CIK: 1620524DEIncorporated: 2014-04-29

Current Offering

$25,000
Target Amount
$5,000,000
Maximum Amount
2023-02-28
Deadline

Security Details

Type: Crowd SAFE (Simple Agreement for Future Equity)
Price per share: $1.00
Shares offered: 25,000+

Offering Costs

Cash commission: 6%
At the conclusion of the offering, the issuer shall pay a fee of six percent (6%) of the amount raised in the offering to the Intermediary.
Equity compensation: 2%
The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the offering.

Financial Reports

Offering via Republic

Offering History

As of 2022-09-02
Raising $25,000 -$5,000,000 via 25,000+ shares of crowd SAFE (Simple Agreement for Future Equity) at $1.00 per share
Deadline: 2023-02-28
Filing date2022-09-02
Current employees9
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$337,233
Cash equi prior fiscal year$516,897
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$155,400
Net income most recent fiscal year-$2,007,144.00
Net income prior fiscal year-$790,983.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$9,761,500
Short term debt prior fiscal year$9,110,917
Tax paid most recent fiscal year-$110,221.00
Tax paid prior fiscal year$51,772
Total asset most recent fiscal year$1,547,848
Total asset prior fiscal year$2,069,171

Company Information

Corporation
DE
2014-04-29

Latest Metrics

Employees9
Total Assets$1,547,848
Cash on Hand$337,233
Revenues$0.00
Net Income-$2,007,144.00

Crowdfunding Portals

This company is raising funds through this portal